Transversus Abdominis Plane Catheter Following Kidney Transplantation
Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
Continuous Infusion of Local Anesthetic After Kidney Transplantation
This is a phase III, randomized, double-blinded, sham-controlled trial comparing the use of a
continuous infusion of local anesthetic via transversus abdominis plane (TAP) catheter to a
saline infusion (sham) via TAP catheter along with standard postoperative analgesia in
patients undergoing kidney transplantation. Patients will have a TAP catheter placed at the
time of kidney transplantation by the surgical team under direct vision. They are then
randomized to a continuous infusion of local anesthetic or saline for 48 hours
postoperatively. Both groups will receive a standard postoperative analgesic regimen
including a Patient Controlled Analgesic (PCA) pump and multimodal analgesics including
acetaminophen and gabapentin.